comparemela.com

Arthrosi Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

URAT1 Inhibitor Beats Allopurinol for Treating Gout Arthritis With Tophi

AR882 is a novel and selective URAT1 inhibitor currently in clinical stage development for the treatment of gout with tophi.

Energy computer tomographyAmerican college of rheumatologyAmerican collegeRobert keenanArthrosi therapeuticsDual energy computer tomography

URAT1 Inhibitor Beats Allopurinol for Treating Gout Arthritis With Tophi

The investigational drug AR882 appeared more effective and safer than allopurinol monotherapy in a phase 2 trial. AR882 is a novel and selective URAT1 inhibitor currently in clinical stage development for the treatment of gout with tophi.

Energy computer tomographyEnergy computed tomographyAmerican college of rheumatologyAmerican collegeRobert keenanArthrosi therapeuticsDual energy computer tomographyDual energy computed tomography

Sustained Serum Urate Reduction for Gout Patients Observed with AR882

In this data shown at ACR 2023, the URAT1 inhibitor known as AR882 showed promising phase 2b data for patients with gout.

San diegoUnited statesRobertt keenanEnergy computer tomographyAmerican college of rheumatology convergenceTrial using dual energy computed tomographyAmerican college of rheumatologyAmerican collegeDual energy computer tomographyArthrosi therapeuticsChronic gouty arthritisSubcutaneous tophiProof of concept trial using dual energy computedRheumatology convergence

Novel Gout Drug Aces Mid-Stage Tests

Mechanism different from currently available therapies

San diegoUnited statesRobert keenanJohn geverAmerican college of rheumatologyArthrosi therapeuticsAmerican collegeManaging editor

Arthrosi to Present Positive Phase 2 Data for its Novel Selective URAT1 Inhibitor AR882 in Patients with Tophaceous Gout at ACR Convergence 2023

/PRNewswire/ Arthrosi Therapeutics, Inc., a clinical-stage biotechnology company developing treatments for gout that dissolve uric acid crystals and prevent.

San diegoUnited statesAlex loboLitain yehShunqi yanEuropean alliance of associationsTrial using dual energy computed tomographyArthrosi therapeutics incEnergy computed tomographyAmerican college of rheumatologyStern investor relations incRobert keenanChief medical officerDual energy computed tomographyChief executive officer litain yehChronic gouty arthritis

vimarsana © 2020. All Rights Reserved.